NYSE:PFE - Pfizer Stock Price, News & Analysis

Pfizer trades on the New York Stock Exchange (NYSE) under the ticker symbol "PFE."

Pfizer announced a quarterly dividend on Thursday, June 27th. Shareholders of record on Friday, August 2nd will be paid a dividend of $0.36 per share on Tuesday, September 3rd. This represents a $1.44 annualized dividend and a yield of 4.09%. The ex-dividend date is Thursday, August 1st. View Pfizer's Dividend History.

Pfizer declared that its board has approved a stock repurchase program on Friday, December 14th 2018, which allows the company to repurchase $10,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 3.8% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's leadership believes its stock is undervalued.

Pfizer Inc. (NYSE:PFE) posted its earnings results on Monday, July, 29th. The biopharmaceutical company reported $0.80 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.75 by $0.05. The biopharmaceutical company had revenue of $13.26 billion for the quarter, compared to analyst estimates of $13.43 billion. Pfizer had a net margin of 23.58% and a return on equity of 28.10%. Pfizer's revenue was down 1.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.77 earnings per share. View Pfizer's Earnings History.

Pfizer is scheduled to release their next quarterly earnings announcement on Tuesday, October 29th 2019. View Earnings Estimates for Pfizer.

Pfizer issued an update on its FY19 earnings guidance on Monday, July, 29th. The company provided EPS guidance of $2.76-2.86 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.91. The company issued revenue guidance of $50.5-52.5 billion, compared to the consensus revenue estimate of $53.45 billion.

17 Wall Street analysts have issued 1-year target prices for Pfizer's shares. Their forecasts range from $40.00 to $55.00. On average, they expect Pfizer's stock price to reach $46.5625 in the next twelve months. This suggests a possible upside of 32.4% from the stock's current price. View Analyst Price Targets for Pfizer.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pfizer in the last year. There are currently 12 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Pfizer.

Headlines about PFE stock have been trending negative this week, InfoTrie reports. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Pfizer earned a media sentiment score of -2.3 on InfoTrie's scale. They also assigned media coverage about the biopharmaceutical company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Pfizer.

Pfizer saw a increase in short interest in July. As of July 31st, there was short interest totalling 67,951,100 shares, an increase of 17.7% from the June 30th total of 57,720,500 shares. Based on an average daily trading volume, of 24,920,000 shares, the short-interest ratio is currently 2.7 days. Currently, 1.2% of the company's stock are short sold. View Pfizer's Current Options Chain.

Some companies that are related to Pfizer include Johnson & Johnson (JNJ), Roche Holdings AG Basel (RHHBY), Merck & Co., Inc. (MRK), Novartis (NVS), Abbott Laboratories (ABT), Novo Nordisk A/S (NVO), AstraZeneca (AZN), Eli Lilly And Co (LLY), Sanofi (SNY), GlaxoSmithKline (GSK), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Bayer (BAYRY), Celgene (CELG) and Zoetis (ZTS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Pfizer investors own include AT&T (T), Cisco Systems (CSCO), Johnson & Johnson (JNJ), General Electric (GE), Verizon Communications (VZ), Intel (INTC), Exxon Mobil (XOM), Bank of America (BAC), Merck & Co., Inc. (MRK) and Walt Disney (DIS).

Pfizer's stock is owned by many different of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (8.01%), Price T Rowe Associates Inc. MD (1.69%), Northern Trust Corp (1.37%), Bank of New York Mellon Corp (1.06%), Morgan Stanley (0.84%) and Fisher Asset Management LLC (0.79%). Company insiders that own Pfizer stock include Alexander R Mackenzie, Charles H Hill, Dawn Rogers, Douglas M Lankler, Frank A Damelio, Ian C Read, Kirsten Lund-Jurgensen, Laurie J Olson, Loretta V Cangialosi, Mikael Dolsten, Pfizer Inc, Rady A Johnson, Sally Susman and W Don Cornwell. View Institutional Ownership Trends for Pfizer.

PFE stock was sold by a variety of institutional investors in the last quarter, including Barrow Hanley Mewhinney & Strauss LLC, Barrow Hanley Mewhinney & Strauss LLC, Price T Rowe Associates Inc. MD, Marshall Wace North America L.P., AQR Capital Management LLC, Quest Capital Management Inc. ADV, Vanguard Group Inc. and Acadian Asset Management LLC. Company insiders that have sold Pfizer company stock in the last year include Alexander R Mackenzie, Dawn Rogers, Douglas M Lankler, Frank A Damelio, Mikael Dolsten and Rady A Johnson. View Insider Buying and Selling for Pfizer.

PFE stock was purchased by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Natixis, Invesco Ltd., Thoroughbred Financial Services LLC, Railway Pension Investments Ltd, Fisher Asset Management LLC, Jensen Investment Management Inc. and California Public Employees Retirement System. View Insider Buying and Selling for Pfizer.

Shares of PFE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PFE stock can currently be purchased for approximately $35.18.

Pfizer has a market capitalization of $194.58 billion and generates $53.65 billion in revenue each year. The biopharmaceutical company earns $11.15 billion in net income (profit) each year or $3.00 on an earnings per share basis. Pfizer employs 92,400 workers across the globe.View Additional Information About Pfizer.

The official website for Pfizer is http://www.pfizer.com/.

Pfizer's mailing address is 235 EAST 42ND STREET, NEW YORK NY, 10017. The biopharmaceutical company can be reached via phone at 212-733-2323.